A new trading day began on Tuesday, with Windtree Therapeutics Inc (NASDAQ: WINT) stock price down -10.42% from the previous day of trading, before settling in for the closing price of $0.16. WINT’s price has ranged from $0.16 to $14.75 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -25.00%. Meanwhile, its annual earnings per share averaged 94.00%. With a float of $10.99 million, this company’s outstanding shares have now reached $11.05 million.
The extent of productivity of a business whose workforce counts for 15 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Windtree Therapeutics Inc (WINT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Windtree Therapeutics Inc is 0.52%, while institutional ownership is 1.48%. The most recent insider transaction that took place on Oct 08 ’24, was worth 4,942. In this transaction President and CEO of this company bought 5,431 shares at a rate of $0.91, taking the stock ownership to the 8,638 shares.
Windtree Therapeutics Inc (WINT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 94.00% per share during the next fiscal year.
Windtree Therapeutics Inc (NASDAQ: WINT) Trading Performance Indicators
Here are Windtree Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -18.63, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -2.86 in one year’s time.
Technical Analysis of Windtree Therapeutics Inc (WINT)
The latest stats from [Windtree Therapeutics Inc, WINT] show that its last 5-days average volume of 14.98 million was superior to 8.68 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 2.63%. Additionally, its Average True Range was 0.04.
During the past 100 days, Windtree Therapeutics Inc’s (WINT) raw stochastic average was set at 0.06%, which indicates a significant decrease from 1.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.28% in the past 14 days, which was lower than the 142.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3618, while its 200-day Moving Average is $3.3565. Now, the first resistance to watch is $0.1521. This is followed by the second major resistance level at $0.1624. The third major resistance level sits at $0.1692. If the price goes on to break the first support level at $0.1350, it is likely to go to the next support level at $0.1282. The third support level lies at $0.1179 if the price breaches the second support level.
Windtree Therapeutics Inc (NASDAQ: WINT) Key Stats
With a market capitalization of 1.57 million, the company has a total of 11,049K Shares Outstanding. Currently, annual sales are 0 K while annual income is -20,290 K. The company’s previous quarter sales were 0 K while its latest quarter income was -2,750 K.
